SELECTIVE AGENTS FOR MUSCARINIC RECEPTORS LINKED TO PHOSPHOINOSITIDE BREAKDOWN

被引：18

作者：

NORONHABLOB, L

CANNING, B

COSTELLO, D

KINNIER, WJ

机构：

来源：

关键词：

D O I：

10.1016/0014-2999(88)90093-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：161 / 167

页数：7

共 32 条

[1] AKHTAR RA, 1987, J PHARMACOL EXP THER, V243, P624
[2] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O
SCHILD, HO
[J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
[3] AN M2 MUSCARINIC RECEPTOR SUBTYPE COUPLED TO BOTH ADENYLYL CYCLASE AND PHOSPHOINOSITIDE TURNOVER
ASHKENAZI, A
WINSLOW, JW
PERALTA, EG
PETERSON, GL
SCHIMERLIK, MI
CAPON, DJ
RAMACHANDRAN, J
[J]. SCIENCE, 1987, 238 (4827) : 672 - 675
[4] HETEROGENEITY OF THE M1 MUSCARINIC RECEPTOR SUBTYPE BETWEEN PERIPHERAL LUNG AND CEREBRAL-CORTEX DEMONSTRATED BY THE SELECTIVE ANTAGONIST AF-DX 116
BLOOM, JW
HALONEN, M
SEAVER, NA
YAMAMURA, HI
[J]. LIFE SCIENCES, 1987, 41 (04) : 491 - 496
[5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6] INOSITOL PHOSPHOLIPID HYDROLYSIS IN RAT CEREBRAL CORTICAL SLICES .1. RECEPTOR CHARACTERIZATION
BROWN, E
KENDALL, DA
NAHORSKI, SR
[J]. JOURNAL OF NEUROCHEMISTRY, 1984, 42 (05) : 1379 - 1387
[7] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8] DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257
[9] PHARMACOLOGICAL EVIDENCE FOR SELECTIVE-INHIBITION OF GASTRIC-ACID SECRETION BY TELENZEPINE, A NEW ANTIMUSCARINIC DRUG
ELTZE, M
GONNE, S
RIEDEL, R
SCHLOTKE, B
SCHUDT, C
SIMON, WA
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 112 (02) : 211 - 224
[10] FISHER SK, 1987, MOL PHARMACOL, V32, P81